论文部分内容阅读
目的 本文旨在复习飞行员肺癌相关文献,并探讨高性能战斗机飞行员肺癌肺叶切除后的航空医学鉴定思路和标准. 方法结合1例高性能战斗机飞行员左下肺腺癌的临床诊断、手术治疗、康复情况及健康鉴定和康复后的飞行情况,复习相关文献,对高性能战斗机飞行员肺癌肺叶切除后的医学鉴定进行探讨. 结果该飞行员有左下肺孤立性结节病史10年,无主诉及临床症状,经肺CT检查提示结节影较前变大并伴毛刺状,正电子发射断层摄影检查呈异常放射性浓聚灶,临床诊断为肺癌.行左下肺叶切除术及淋巴结清扫术,术后病理结果为高分化腺癌,未进行放疗、化疗.飞行暂不合格,地面观察1年,经临床检查未见肿瘤复发及转移,心、肺功能检查大致正常,加速度耐力检查合格,飞行结论为合格.恢复飞行12个月,飞行时间65 h,来院复查未见异常. 结论肺癌肺叶切除的高性能战斗机飞行员,术后无复发、转移,心肺功能及加速度耐力良好者,可飞行合格.“,”Objective This paper is to explore the aeromedical evaluation standard of the high performance fighter pilot with pulmonary adenocarcinoma after pulmonary lobectomy. Methods Based on the information of clinical diagnosis, treatment, recovery, aeromedical evaluation, re-flight status of a male high performance fighter pilot with pulmonary adenocarcinoma, we reviewed some literatures, and explored the medical evaluation of the high performance fighter pilot after pulmonary lobeetomy. Results With a solitary pulmonary nodule for 10 years, the patient had no chiefcomplaint. And there was no symptom on him. Lung cancer was diagnosed by examination of computed tomography(CT) and positron emission tomography(PET). Lobectomy of inferior lobe of left lung and radical correction of lymph node were operated. The pathological diagnosis was well-differentiated adenocarcinoma. However neither the radiotherapy nor the chemotherapy was adopted.After one-year medical observation, there was no evidence that the cancer recurrence or metastasis.Because the cardiorespiratory function and the G-tolerance of the patient were examined and qualified,he was allowed to returned to flight and had navigated the high performance fighter for 65 hours in thenext 12 months. Then he returned the hospital to reexamined, and there was no evident clinical abnormity to be found again. Conclusions After the pulmonary lobectomy, there is no evidence that the cancer recurrence or metastasis, The evaluation of the cardiorespiratory function and G-tolerance are examined and qualified, the high performance fighter pilot could be qualified for flying.